IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.065
+0.040 (1.32%)
Aug 22, 2025, 5:29 PM CET

IRLAB Therapeutics AB Market Cap

IRLAB Therapeutics AB has a market cap or net worth of 266.28 million as of August 29, 2025. Its market cap has decreased by -66.23% in one year.

Market Cap
266.28M
Enterprise Value
288.39M
Revenue
75.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.07

Market Cap Chart

Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 266.28M, a decrease of -35.52%. That is a compound annual growth rate of -5.03%.

History

DateMarket Cap% Change
Aug 28, 2025266.28M-52.24%
Dec 30, 2024557.59M43.33%
Dec 29, 2023389.01M-80.42%
Dec 30, 20221.99B-12.75%
Dec 30, 20212.28B4.76%
Dec 30, 20202.17B37.75%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Swedish Orphan Biovitrum AB 101.89B
Sectra AB 64.55B
Getinge AB 56.16B
Camurus AB 43.17B
Medicover AB 40.08B
Asker Healthcare Group AB 38.16B
BioArctic AB 27.36B
AddLife AB 21.53B
Market Cap Rankings